Quest Diagnostics Inc
Change company Symbol lookup
Select an option...
DGX Quest Diagnostics Inc
DPW DPW Holdings Inc
IWN iShares Russell 2000 Value ETF
XNXCX Nuveen California Select Tax-Free Income Portfolio
AMGN Amgen Inc
AMSC American Superconductor Corp
CVBF CVB Financial Corp
PHG Koninklijke Philips NV
IVR Invesco Mortgage Capital Inc
CORE Core-Mark Holding Company Inc
Go

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Premarket

Last Trade
Delayed
$124.00
-0.39 (-0.31%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$123.83
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
23

10-day average volume:
1,488,521
23

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, January 18, 2021
Black and Hispanic/Latinx Americans Less Confident in Ability to Access COVID-19 Vaccines, Treatments and Healthcare than White Americans, Finds Quest Diagnostics Health Trends(TM) Analysis

A new Quest Diagnostics Health Trends(TM) study finds that Black and Hispanic/Latinx Americans are nearly two times as likely as White Americans to say their access to COVID-19 vaccines, treatments and healthcare, once available, is worse than other...(PR Newswire)

Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to provide genomic sequencing to identify...(PR Newswire)

January 13, 2021
Quest Diagnostics To Release Fourth Quarter And Full Year 2020 Financial Results On February 4

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2020 results on Thursday, February 4, 2021, before the market opens. It will...(PR Newswire)

December 22, 2020
Hackensack Meridian Health and Quest Diagnostics Partner to Deliver High-Value, Innovative Laboratory Services

Hackensack Meridian Health (HMH), the largest, most comprehensive and truly integrated health care network in New Jersey, and Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, are teaming up to enhance...(PR Newswire)

December 18, 2020
Bell Buckle Holdings Appoints Don Zeppenfeld as an Independent Director Board Member

Naples, Florida--(Newsfile Corp. - December 18, 2020) - Bell Buckle Holdings, Inc. (OTC Pink: BLLB) is proud to announce the addition of Don Zeppenfeld to the Company's Board of Directors. As an Independent Board Member, his roles will be Corporate...(Newsfile)

December 17, 2020
Leading Black Clergy Meet with Dr. Fauci and Nation's Top Doctors in Historic Summit to Address COVID-19 in the Black Community

Choose Healthy Life Black Clergy Action Plan, a group of the nation's leading Black clergy led by Rev. Al Sharpton and Rev. Calvin O. Butts, III, convened a meeting yesterday with Dr. Anthony Fauci, Director of the National Institute of Allergy and...(PR Newswire)

Quest Diagnostics Selects Qualtrics EmployeeXM and CustomerXM, Empowering Coordinated Action for Improvement all on One Platform

Qualtrics, the leader in customer experience and creator of the experience management category, today announced that Quest Diagnostics, one of the largest clinical laboratory testing companies in the United States, has selected Qualtrics...(PR Newswire)

Quest Diagnostics and The Commons Project to Deliver Convenient Access to Lab Data -- Including COVID-19 Test Results -- Through the CommonHealth App

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and The Commons Project, a non-profit public trust dedicated to building and operating global digital platforms and services for public good, today...(PR Newswire)

December 16, 2020
Quest Diagnostics Raises Outlook for Full Year 2020

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today raised its financial outlook for full year 2020. https://mma.prnewswire.com/media/200883/quest_diagnostics_incorporated_logo_logo.jpg (PR Newswire)

December 10, 2020
Point of Care Diagnostics Market to Exhibit a Decent CAGR of 7.3% and Hit USD 23.36 Billion by 2027; Increasing Cases of Acute Diseases to Spur Sales Opportunities, states Fortune Business Insights(TM)

The global Point of Care Diagnostics Market size is expected to reach USD 23.36 billion by 2027, exhibiting a CAGR of 7.3% during the forecast period. The market size stood at USD 18.45 billion in 2019. The growing acceptance of POC testing kits in...(Globe Newswire)

December 09, 2020
New Quest Diagnostics Health Trends(TM) Survey Reveals COVID-19 Testing Hesitancy Among Americans, With 3 of 4 Avoiding a Test When They Believed They Needed One

A new Quest Diagnostics Health Trends(TM) study finds that three in four Americans who believed they needed a COVID-19 test (74%) chose not to get one, or delayed getting one, primarily due to concerns about exposure to the SARS-CoV-2 virus (30%). (PR Newswire)

December 04, 2020
Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 and Flu Combination Test for Use with Home-Collected Samples

Today, the U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and B (flu). The FDA authorized Quest Diagnostics RC COVID-19 +Flu RT-PCR Test for...(PR Newswire)

November 30, 2020
Infectious Disease Point of Care Diagnostics Market to Rise at 17.4% CAGR and Reach $3371.1 Million by 2027; Increasing Investments in Product R&D will Bode well for Market Growth, says Fortune Business Insights(TM)

The global Infectious Disease Point of Care Diagnostics Market size is projected to reach USD 3,371.1 million by the end of 2027. The presence of several large-scale companies in this sector will emerge in favor of market growth. According to a...(Globe Newswire)

November 24, 2020
Quest Diagnostics Earns Gold Status in American Heart Association's 2020 Workplace Health Achievement Index

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has achieved Gold status in the American Heart Association's 2020 Workplace Health Achievement Index, ranking the company's...(PR Newswire)

November 23, 2020
Quest Diagnostics Teams Up with Two Health Systems to Deliver High-Value, Innovative Laboratory Services

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced professional lab services relationships with two hospital health systems to enhance the quality and value of diagnostic services to...(PR Newswire)

November 18, 2020
Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.56 per share, payable on February 3, 2021 to shareholders of record...(PR Newswire)

November 16, 2020
Heads Up Health Closes $1.35M Seed Round Lead by Innosphere Ventures

Innosphere Ventures' seed-stage venture capital fund has announced its investment in Heads Up Health (Heads Up), a leading digital health analytics company with a software platform that instantly compiles and organizes a complete medical history...(Globe Newswire)

November 12, 2020
IVD Market is Forecast to Rise at 4.5% CAGR and Reach USD 87.11 Billion by 2026; Adoption of New Techniques for Rapid Disease Diagnosis Will Encourage Growth, says Fortune Business Insights(TM)

According to the report, the global IVD Market size was valued at USD 61.22 Billion in 2018 is predicted to reach USD 87.11 Billion by 2026, exhibiting a CAGR of 4.5% during the forecast period. North America generated a revenue of USD 23.09...(Globe Newswire)

November 05, 2020
Blumenthal Nordrehaug Bhowmik De Blouw LLP, File a Class Action Lawsuit Against Quest Diagnostics Incorporated, Alleging Violations of California Labor Law

The San Bernardino employment law attorneys at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action complaint alleging that Quest Diagnostics Incorporated failed to provide accurate wages and legally required breaks. The Quest...(PR Newswire)

November 03, 2020
Quest Diagnostics To Speak At The Credit Suisse 29th Annual Virtual Healthcare Conference

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Credit Suisse 29th Annual Virtual Healthcare Conference. Steve Rusckowski, Chairman...(PR Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.